Key Applications and Strategies of Overexpression Cell Lines in Drug Target Discovery and Validation

Core Role of Overexpression Cell Lines in Target Functional Studies

In the early stages of drug discovery, clarifying the biological function of candidate targets is the foundation for determining subsequent development directions. Overexpression cell lines introduce the gene of interest into specific host cells (such as HEK293, CHO-K1, etc.), enabling high-abundance expression of the target protein within the cells, thereby simulating scenarios of target overactivation or abnormal expression under disease conditions. Researchers can use such models to observe phenotypic changes such as cell proliferation, apoptosis, and migration, and preliminarily determine the association between the target and the disease. For example, in cancer research, constructing a cell line overexpressing a certain receptor tyrosine kinase can be used to detect phosphorylation levels of downstream signaling pathways (such as MAPK, PI3K/AKT), thereby screening lead compounds that may block that pathway. Such experiments typically require an empty vector control to exclude the effect of the vector backbone itself on cell phenotype, ensuring the reliability of results.

Application Strategies of Overexpression Cell Lines in High-Throughput Screening

Another important application area of overexpression cell lines is high-throughput drug screening. By stably expressing the target of interest downstream of a reporter gene system (such as luciferase, GFP), or directly utilizing the proliferation dependence of overexpression cell lines, cell activity-based screening models can be constructed. In 384-well or 1536-well plates, researchers can simultaneously evaluate the inhibitory or activating effects of thousands of compounds on target-overexpressing cell lines and calculate parameters such as half-maximal inhibitory concentration. Such models require cell lines with uniform expression levels, stable passaging characteristics, and low batch-to-batch variation. It is generally recommended to use cell lines that have undergone monoclonal selection and have a cryopreserved working cell bank to ensure reproducibility of screening data. In addition, for targets whose activity is difficult to detect directly (such as G protein-coupled receptors), downstream second messenger detection systems can be introduced; overexpression cell lines can provide a stronger signal window in such systems and reduce false positive rates.

Value of Overexpression Cell Lines in Specificity Assessment of Candidate Compounds

Determining the selectivity of candidate compounds for the target of interest is a key step in avoiding off-target toxicity. Parallel testing using cell lines overexpressing different subtypes or homologous proteins can compare differences in compound sensitivity between target X and target Y. For example, in kinase inhibitor development, constructing cell lines overexpressing wild-type and mutant kinases can reveal whether compounds exhibit cross-reactivity with drug-resistant mutation sites. Only when a compound shows significant inhibitory activity on the target overexpression cell line and no activity on unrelated target overexpression cell lines can its selectivity be preliminarily determined. Such validation experiments typically require multiple concentration gradients and Western blot or ELISA to detect downstream markers of the target protein, in order to exclude interference from the cell counting method itself.

Quality Control Points in Constructing Overexpression Cell Lines

To ensure the accuracy of the above applications, the construction process of overexpression cell lines should follow standardized procedures. After transfection or infection, antibiotic selection (such as puromycin, G418) or flow sorting is generally used to obtain stably expressing populations. Subsequently, monoclonal isolation is performed, and each clone is tested for gene copy number, mRNA, and protein expression levels. Common methods include qPCR, Western blot, and immunofluorescence. Regular testing for mycoplasma contamination of cell lines is also required, and expression stability during passaging should be evaluated (typically recommended for more than 10 consecutive passages). For overexpression cell lines used in in vivo experiments, consideration should also be given to whether cell surface markers have changed and whether tumorigenicity is abnormal. The use of unvalidated pooled clones for key efficacy experiments is not recommended, as uneven expression may lead to result drift.

Conclusion

As a standard model in the drug discovery toolbox, the construction quality of overexpression cell lines directly affects target validation efficiency and screening throughput. Rational experimental design and strict control of the construction process can enable overexpression cell lines to continue to provide value in target functional analysis, high-throughput screening, and selectivity assessment.